Clinical Trial: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)

Share this article:
Clinical Trial: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)

Sponsor and Collaborators

AIO-Studien-gGmbH, Fresenius Biotech GmbH

Principal Investigator
Florian Lordick, Prof. Dr., Medizinische Klinik III, Städtisches Klinikum Braunschweig gGmbH

ClinicalTrials.gov Identifier
NCT01504256
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Gastrointestinal Cancer Clinical Trials

Clinical Trial: Biomarker Analysis of Gastrointestinal Cancer

Clinical trial focusing on biomarker analysis and gastrointestinal cancer. Biomarker Analysis of Gastrointestinal Cancer

Clinical Trial: Immunonutrition and Quality of Life of Cancer Patients Undergoing ...

Clinical trial focusing on immunonutrition and cancer patients.Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment (Neoimmune)

Clinical Trial: S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer

Clinical trial focusing on S-1, oxaplatin, irinotecan and gastrointestinal cancer. S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer.